FDA grants approval for Pfizer’s Prevnar 13 to prevent pneumococcal pneumonia

American pharmaceutical company Pfizer has received the US Food and Drug Administration (FDA) approval for its Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) to prevent pneumonia and other invasive diseases.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news